RNA-containing type-C viruses have been classified into two broad groups of viruses based on their biological properties. One type, the "leukemia viruses," are able to productively infect fibroblast cell cultures without morphologically altering the cells; the other type, "sarcoma viruses," are transforming viruses and produce morphological transformation of fibroblasts in cell culture. The helper type-C viruses or leukemia viruses have been isolated from many species. Isolates of sarcoma viruses have been more limited but such transforming viruses have been isolated from chickens (22) , mice (7, 19) , rats (9, 14) , cats (8, 25) , and recently from a woolly monkey (27) . The mode of isolation of sarcoma virus has varied from species to species. For example, in the case of sarcoma virus isolates from cats (8, 25) and the woolly monkey (27) , transforming virus was isolated directly from extracts of spontaneously occurring tumors. In mice, several strains of sarcoma virus have been isolated. One strain, isolated from a spontaneously occurring osteosarcoma (7) , the FBJ strain, only recently has been studied in cell culture (16) and little is known about its genome. Three other isolates of murine sarcoma virus have been obtained by animal passage of nontransforming helper type-C virus and the subsequent isolation from the stock of two viruses, the original helper, and a transforming or sarcoma virus which can produce nonlymphoid soft tissue tumors. Examples of such experiments are the isolation of Moloney sarcoma virus in mice (19) , the isolation of the Kirsten sarcoma virus by passage of Kirsten murine erythroblastosis virus in rats (14) , and the isolation of the Harvey sarcoma virus by passage of the Moloney helper type-C virus in rats (9) .
Earlier studies (3, 24) (10) .
Viruses. The source and growth of the Kirsten strain of murine leukemia virus (Ki-MuLV) and Kirsten sarcoma virus (Ki-SV') has been described (3). The source of' Molonev leukemia virus (MoMuLV) has also been reported (2) . The Gibbon ape type-C virus (GaLV) (1. 3) was obtained from a human cell line producing the Gibbon ape type-C virus (4 M sodium chloride, and 10 3 M EDTA (TNE). The resuspended virus was lavered on top of' a discontinuous sucrose gradient in an SW 27 rotor tube containing the following sucrose solutions in the same TNE buffer: 4 ml of 605 sucrose, 12 ml of 30% sucrose, and 10 ml of 20% sucrose. The gradients were spun for 16 to 20 h at 25,000 rpm, 4 C, and the virus band on the 60c4 cushion was aspirated. The virus was then concentrated and removed from the sucrose by dilution in TNE buffer minus sucrose and by centrifugation at 100,000 x g at 4 C for 2 h. The pelleted virus was then suspended in TNE buffer containing FT SDS and lavered on top of' a 15 to 30%. glycerol gradient containing TNE and 0.1% SDS. It was centrifuged for 2 h in an SW 41 rotor at 35,000 rpm at 20 C. The gradient was punctured and collected from below into a 0.4-ml fraction and the [3H]RNA peak centrif'uging at 60 to 70S was pooled, dialyzed against TNE, and lyophilized. It was stored at -20 C and lyophilized until use. (24) . One set was homologous to nucleic acid sequences found in the Kirsten strain of mouse type-C virus. The other set was found to be homologous to a [3H ]DNA transcript which was synthesized in an endogenous reverse transcriptase reaction containing rat type-C virus(es). Since Kirsten sarcoma virus was formed by passage of Kirsten mouse type-C virus in rats (14), we proposed that Kirsten sarcoma virus might represent a recombinant between Ki-MuLV and sequences found in rat cells.
The Harvey strain of murine sarcoma virus was isolated independently by passage of Moloney mouse type-C virus in rats (9) . Thus, we undertook similar hybridization experiments to ascertain if the Harvey sarcoma virus also was a recombinant between a mouse type-C virus and nucleic acid sequences found in rat cells. Our results indicate that the Harvey strain of murine sarcoma virus also contains at least two distinguishable sets of nucleic acid sequences. One set is homologous to nucleic acid sequences present in the Moloney strain of' murine type-C virus; the other set is present in sequences found in endogenous virus(es) released from NRK rat cells. Thus, in both independent cases, the formation of a sarcoma virus was accompanied by a recombinant event. In mixing experiments, the rat type-C viral nucleic acid sequences were found to be similar for both the Kirsten and Harvey sarcoma viruses. However, we do not know whether the rat sequences that we detect are responsible for the transforming activity of each of these sarcoma viruses.
In addition to the evidence that the Kirsten and Harvey strains of sarcoma virus have gained new sequences not present in the mouse type-C viruses which went into their formation, the present studies and earlier studies have demonstrated that each of these two sarcoma viruses also contain mouse type-C viral sequences. However, in each case not all of the sequences present in the initial murine mouse type-C virus are detected in the total cellular RNA from nonproducer cells transformed by either the Kirsten sarcoma virus or Harvey sarcoma virus. It is possible that the reason these sequences are missing is that they are present in the DNA of such nonproducer cells but are not transcribed in such nonproducer cells. Another possibility is that the sequences have been deleted either during or after the process of reassortment and/or recombination and are now missing from the sarcoma virus genomes. Although the evidence is not yet definitive, the latter interpretation would be supported by the observations of Maisel and her co-workers (18) , which have shown that both Kirsten and Harvey strains of sarcoma virus have a smaller genome than is present in a complete murine type-C helper virus. This would be consistent with the idea that part of the initial genome had been deleted during the process of integration, reassortment or recombination. In addition, preliminary studies of the DNA in such sarcoma virus-transformed cells would also suggest that only part of' the Moloney or Kirsten type-C genomes are present in the DNA of the sarcoma virus-transformed nonproducer cells. Such a result would also suggest that the murine type-C viral sequences have been deleted from each of the sarcoma virus genomes and that this is the explanation for the lack of' sequences found in the RNA of' such nonproducer cells. However, additional experiments will be necessary to prove that these viruses are in fact deletion mutants of the complete MuLV genome and to quantitate the portion of the genome deleted.
The current study seems to indicate a similarity in the genesis of both mammalian sarcoma viruses and avian sarcoma viruses. It has been demonstrated that several avian sarcoma viruses, in contrast to the murine sarcoma viruses, have the ability to both replicate and transform fibroblasts in cell culture. Analysis of the size of the sarcoma virus genome versus the helper genome has indicated that the competent sarcoma virus genome is larger in size than the helper virus genome (5, 6, 15) . The larger sarcoma virus genome has been designated the a subunit, and the smaller helper virus genome has been designated the b subunit. A model has been suggested by Duesberg and Vogt (5, 6 ) that the b subunit has gained information, designated X, to form the larger a subunit. Thus a = b + X (15 (18) , by hybridization experiments our data demonstrate the gain of information (analogous to X) not present in the initial Kirsten type-C or Moloney type-C viruses. Thus, the difference between the competent avian sarcoma virus and the defective mammalian sarcoma virus might simply be the deletion of' some of helper type-C viral information during or after the process of formation of the sarcoma virus. This deletion would render the sarcoma virus defective for replication but not for transformation. For both the avian sarcoma virus and mammalian sarcoma virus, however, a gain of information by initial helper virus genome would have occurred to produce the transforming virus. However, in neither the avian system nor as previously noted in the case of Ki-SV (24) can we yet identify the exact source of the information in either sarcoma virus which codes for the maintenance of transformation. Nevertheless, the formation of transforming type-C virus from the helper virus in both avian and mammalian systems is analogous to the process of' transduction of information by bacterial viruses. In fact, sarcoma viruses defective for replication which are apparent deletion mutants derived from competent sarcoma viruses for replication have been reported for avian sarcoma virus as well (12) . Whether or not such a process of' recombination or transduction, or both, is necessary for the formation of other type-C viruses which can transform other types of cells, such as lymphoreticular cells, is unknown at this time. However, it is tempting to speculate that there are nononcogenic type-C viruses which acquire their oncogenicity through similar recombinational events (26) in the case of production of leukemia-producing type-C viruses as well as sarcoma-producing type-C viruses.
